These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1882 related articles for article (PubMed ID: 32592501)

  • 1. The cytokine storm and COVID-19.
    Hu B; Huang S; Yin L
    J Med Virol; 2021 Jan; 93(1):250-256. PubMed ID: 32592501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.
    Shawki MA; Elsayed NS; Mantawy EM; Said RS
    Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):395-409. PubMed ID: 34057871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence.
    Pelaia C; Calabrese C; Garofalo E; Bruni A; Vatrella A; Pelaia G
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.
    Pum A; Ennemoser M; Adage T; Kungl AJ
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33445810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
    Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
    Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions.
    Asrani P; Hassan MI
    Mol Cell Biochem; 2021 Feb; 476(2):675-687. PubMed ID: 33064288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sEH inhibition on the eicosanoid and cytokine storms in SARS-CoV-2-infected mice.
    Edin ML; Gruzdev A; Graves JP; Lih FB; Morisseau C; Ward JM; Hammock BD; Bosio CM; Zeldin DC
    FASEB J; 2024 May; 38(10):e23692. PubMed ID: 38786655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis and treatment of cytokine storm in COVID-19.
    Kim JS; Lee JY; Yang JW; Lee KH; Effenberger M; Szpirt W; Kronbichler A; Shin JI
    Theranostics; 2021; 11(1):316-329. PubMed ID: 33391477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells.
    Hafezi B; Chan L; Knapp JP; Karimi N; Alizadeh K; Mehrani Y; Bridle BW; Karimi K
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm.
    Peng X; Wang Y; Xi X; Jia Y; Tian J; Yu B; Tian J
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):231-247. PubMed ID: 33404925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm.
    Gangemi S; Tonacci A
    Cytokine Growth Factor Rev; 2021 Apr; 58():111-113. PubMed ID: 32938545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.
    Rossi M; Piagnerelli M; Van Meerhaeghe A; Zouaoui Boudjeltia K
    Med Hypotheses; 2020 Nov; 144():110242. PubMed ID: 33254548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Impaired Inflammatory and Innate Immune Response in COVID-19.
    Park SH
    Mol Cells; 2021 Jun; 44(6):384-391. PubMed ID: 34098591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of N-acetyl cysteine (NAC) in preventing cytokine storm in COVID-19: review of current evidence.
    Mohanty RR; Padhy BM; Das S; Meher BR
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2802-2807. PubMed ID: 33829465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Covid-19 cytokine storm by tocilizumab.
    Boretti A; Banik B
    J Med Virol; 2022 Mar; 94(3):823-828. PubMed ID: 34617604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis.
    Kamel NA; Ismail NSM; Yahia IS; Aboshanab KM
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.
    England JT; Abdulla A; Biggs CM; Lee AYY; Hay KA; Hoiland RL; Wellington CL; Sekhon M; Jamal S; Shojania K; Chen LYC
    Blood Rev; 2021 Jan; 45():100707. PubMed ID: 32425294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 95.